It can take years for prostate cancer to turn castration-resistant, when cancer cells stop responding to hormonal therapy.

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

A pivotal trial of an electronic artificial urinary sphincter could herald the future of treating incontinence.

Sophia Kamran, MD, discusses how salvage therapy after biochemical recurrence may improve outcomes for patients with prostate ...

Investigators assessed whether a reported survival disadvantage in men with secondary rectal cancer following prostate cancer radiation therapy vs primary rectal cancer is due to patient ...

The solid cash conversion allows Telix to internally fund organic growth and flexibility to pursue acquisitions. We expect the company to reinvest the majority of earnings into R&D. We forecast ...

(UroToday.com) The American Urological Association (AUA) 2025 Annual Meeting, held in Las Vegas, NV, was host to an advanced prostate cancer podium session. Dr. Alejandro Sanchez presented the results ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

Lara Rodriguez Sanchez, Samir Taneja, Hashim Ahmed, Himanshu Nagar, Edward Schaeffer in a Crossfire: Controversies in Urology debate: discussed if Focal Therapy is a Suitable Option for all Cases with ...

Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate ...

The Nuclear Medicine Department at Ridley-Tree Cancer Center (now part of Sutter Health) has announced greater capabilities to treat prostate cancer using ...